Background CD97 is a member of the epidermal growth factor-seven transmembrane (EGF-TM7) family of adhesion receptors and is broadly expressed on hematopoietic cells. The aim of this study was to investigate the expression of CD97 on hematopoietic stem-and progenitor cells (HSC/HPC).
Introduction
Hematopoietic stem cells (HSC) are capable of extensive self-renewal and confer long-term multilineage repopulating ability upon infusion into a myeloablated recipient. 1 Although human HSC are characterized by only a few cell surface markers, [1] [2] [3] the phenotype of murine HSC is defined by a variety of cell surface molecules. Murine HSC have been identified as cKit POS Thy-1 LO 
Lin
NEG/LO Sca-1 POS . [4] [5] [6] However, this population contains a mixture of HSC and hematopoietic progenitor cells (HPC) that exhibit long-and short-term repopulating ability, respectively. 7 To increase the frequency of HSC with long-term repopulating capacity within this Kit POS Thy-1 LO Lin NEG/LO Sca-1 POS population, further selection using rhodamine-123, wheat germ agglutinin or a combination of anti-CD11b and anti-CD4 antibodies has been used. [8] [9] [10] CD97 is a member of the epidermal growth factorseven transmembrane (EGF-TM7) receptor family. 11, 12 CD97 is characterized by an extended extracellular region comprising several tandemly arranged EGF-like domains coupled to the TM7 region by a spacer. As a result of alternative RNA splicing three isoforms, comprising different numbers of EGF-like domains, are expressed in humans and mice. [12] [13] [14] Except for smooth muscle cells and a restricted set of epithelial tumors, CD97 is only expressed on a broad array of hematopoietic cells including (activated) lymphocytes, granulocytes, monocytes, macrophages and dendritic cells. 15, 16 CD55 (decay accelerating factor), chondroitin sulfate and the integrin α5β1 (also known as VLA-5) have been identified as cellular ligands for CD97. 12, 13, 17, 18, 19 The composition of the EGF domain region defines the ligand specificity of the different CD97 isoforms. The first and second EGF domains interact with CD55, whereas the fourth EGF domain binds chondroitin sulphate. 17, 18, 20 The ligand affinity of the CD97 isoforms differs. While affinity for CD55 is significantly higher for the smaller isoforms, 21, 22 chondroitin sulphate interacts exclusively with the largest isoforms. 18 In this study we investigated the expression of CD97 on HSC and HPC obtained from different mouse strains.
Design and Methods

Animals
Eight to 12-week old male BALB/c and DBA/1 mice were purchased from Charles River (Maastricht, The Netherlands), and male C57BL/6-Ly5.2 mice (8-12 weeks old) were obtained from Bioservices (Uden, The Netherlands). C57BL/6-Ly5.1 congenic recipients were bred in our own facilities and were used at 8-12 weeks of age. The animals were fed commercial rodent chow and allowed acidified water ad libitum and were maintained in the animal facility of the Leiden University Medical Center under conventional conditions. All experimental protocols were approved by the institutional ethics committee on animal experiments.
Antibodies for cell sorting and analysis
CD97 expression was assessed by flow cytometry using a biotinylated hamster anti-murine CD97 monoclonal antibody (clone 1B2) 23 directed against the first EGF-like domain of murine CD97 and was stained with streptavidin-APC or streptavidin-PE-Cy7 (both obtained from Caltag Laboratories, Burlingame, CA, USA). To analyze the phenotype of CD97 subpopulations, cells were stained with FITC-labeled anti-CD8 (clone 53-6.7), anti-CD4 (clone GK1.5), anti-B220 (clone RA3-6B2), anti-CD11b (clone M1/70), anti-GR-1 (clone RB6-8C5), anti-CD3 (clone 145-2C11; all obtained from Pharmingen, San Diego, CA, USA) and anti-TER119 (clone Ter-119; obtained from Caltag Laboratories). These markers are further designated as Lin-markers. Phycoerythrin-labeled anti-CD117 (c-Kit, clone 2B8) and biotinylated anti-CD90.2 (Thy1.2, clone 53-2.1) were obtained from Pharmingen. CD90.2 was stained with streptavidin PE-Cy5. Biotinylated Sca-1 (clone D7) was purchased from Pharmingen and was stained with streptavidin APC-Cy7 (Pharmingen).
Hoechst 33342 staining was performed as previously described. 24 Briefly, bone marrow cells were resuspended in RPMI (Life Technologies, Paisley, Scotland), containing 2% heat inactivated fetal calf serum, 25 mM HEPES, penicillin, streptomycin and Hoechst 33342 (5 µg/mL, Molecular Probes Europe, Leiden, The Netherlands) and incubated for 90 minutes at 37°C. Next the cells were washed in cold medium and maintained at 4°C until analysis on a LSRII flowcytometer (Beckton Dickinson, Mountain View, CA, USA).
Preparation of cell suspensions
Using sterile procedures, bone marrow cells were obtained by flushing femoral, tibial and humeral bones from donor mice with RPMI medium (Life Technologies, Paisley, Scotland) supplemented with 2% heat inactivated fetal calf serum, 10% heparin, penicillin and streptomycin. After incubation with DNAse (1.33 µg/mL), erythrocytes were lysed. Subsequently, the cells were sorted on a FACS Aria (Beckton Dickinson). As a control, total bone marrow cells were sorted for the life-gate, based on forward scatter/side scatter characteristics. All populations used in experiments were of ≥95% purity.
Progenitor cell assays
Colony forming units-granulocyte monocyte (CFU-GM) were cultured as described previously. 25 Briefly, peripheral blood mononuclear cells were cultured in 3.5-cm dishes containing 5×10 5 cells/mL in semisolid medium in the presence of recombinant murine granulocyte-monocyte colony-stimulating factor (1.25 ng/mL, Pharmingen). Bone marrow cells were cultured at a concentration of 5×10 4 cells/mL. After 6 days of culture in a fully humidified atmosphere of 37°C containing 5% CO2, the number of colonies (defined as an aggregate of ≥20 cells) was scored using an inverted light microscope. tomed 96-well plates (Falcon, Etten-Leur, The Netherlands) were overlaid with various dilutions of freshly sorted bone marrow cells to allow limiting dilution analysis of the precursor cells forming hematopoietic clones under the stromal layers. To assay a particular cell suspension, we used eight dilution steps differing by a factor of 2.5, with 15 wells per dilution. The cells were cultured at 33°C in 7% CO2 and were fed weekly by changing half of the medium. Between 7 and 42 days after overlay, all wells were inspected at weekly intervals and scored positive if at least one phase-dark hematopoietic clone (cobblestone area, at least 5 cells) was observed. The CAFC frequencies were calculated using Poisson statistics.
Bone marrow cell transplantation
Recipient mice were irradiated in perspex chambers with a linear accelerator (Philips SL 75-5/6 mV, Philips Medical Systems, Best, The Netherlands) at a dose rate of 98 cGy/min. Total doses of 9.5 Gy (BALB/c and C57BL/6) and 9.0 Gy (DBA/1; lethal irradiation) were administered. Four to 8 hours following total body irradiation, bone marrow cells were injected into the caudal vein in 0.2 mL of saline, containing 0.2% bovine serum albumin.
Statistical analysis
Statistical analyses were performed with the Student's t-test and the log-rank test, using GraphPadPRISM (GraphPad Software, San Diego, CA, USA). p values <0.05 were considered statistically significant.
Results
The CD97 NEG bone marrow cell fraction is enriched in colony-forming cells
To evaluate the expression of CD97 on murine bone marrow cells, primary BALB/c, C57BL/6 and DBA/1 bone marrow cells were stained with anti-CD97 monoclonal antibodies. FACS analysis showed three major populations i.e. CD97 HI , CD97
INT and CD97 NEG cells ( Figure 1A ). The majority of bone marrow cells stained highly positive for CD97 (range 58-67% of total bone marrow cells), while 27-33% showed an intermediate expression of CD97. Only a small proportion of bone marrow cells did not express CD97 (range 4-10%; Figure 1B ). No significant differences were detected between the different strains of mice.
Based on CD97 expression, bone marrow cells were sorted into highly pure CD97 HI , CD97
INT and CD97 NEG populations. Subsequently, CFU-GM colony-forming capacity was analyzed in the different CD97 subsets. Although the frequency of progenitor cells in total bone marrow cells varied between the different mouse strains (3,840±1,086, 8,070±970.6 and 13,251±7,342 CFU-GM per 10 6 cells for BALB/c, C57BL/6 and DBA/1, respectively) the lowest frequency of CFU-GM colonies was detected in the CD97 HI group in all strains. Furthermore, the highest frequency of progenitors was detected in the CD97 NEG population, while the CD97
INT fraction contained colony-forming cells at levels comparable to those in total bone marrow cells ( Figure 1C and 1D). These results indicate that the majority of HPC with colony-forming capacity are present in the CD97 NEG bone marrow cell fraction.
Enrichment of repopulating hematopoietic stem cell in the CD97 INT bone marrow cells subset
To enumerate the frequency of primitive stem cells with long-term repopulating ability in the CD97 HI , CD97
INT and CD97 NEG populations, sorted BALB/c, C57BL/6 and DBA/1 bone marrow cells were tested in CAFC assays.
In bone marrow cells obtained from BALB/c mice, the highest proportion of CAFC-day 7, representing cells with progenitor cell activity, was found in the CD97
NEG fraction compared to in CD97 HI , CD97 INT and total bone marrow cells (Figure 2A) . However, the frequency of CAFC in the CD97 NEG population decreased during the weeks of culture and no CAFC-day 28/35 were present in the CD97 NEG fraction. The CD97 HI bone marrow cells fraction contained very few CAFC throughout the whole culture period and did not contain CAFC-day 28/35. In contrast, the CD97
INT bone marrow cells showed a high frequency of CAFC-day 7 Analysis of bone marrow cells obtained from C57BL/6 and DBA/1 mice indicated that the majority of CAFC-day 7 were found in the CD97
INT population and the frequency of CAFC remained highest in the CD97
INT population throughout the entire culture period (Figure 2A) Figure 2B ).
CD97 INT bone marrow cells are radioprotective in vivo
To investigate the repopulating ability of the different CD97-sorted bone marrow cells fractions, 1×10 INT bone marrow cells showed a radioprotection rate of ≥70% at 150 days following transplantation in all strains ( Figure 3A) . Furthermore, CD97 HI bone marrow cells obtained from C57BL/6 donors gave 40% radioprotection in lethally irradiated congenic recipients. In DBA/1 recipients, CD97
HI and CD97 NEG bone marrow cells gave radioprotection rates of 90% and 67%, respectively (n ≥10; two independent experiments). None of the control mice that received total body irradiation alone (n=6 per strain; two independent experiments) was radioprotected at 8 weeks following transplantation. To confirm that CD97 INT bone marrow cells exhibited long-term repopulating ability, lethally irradiated (9.5 Gy) secondary recipient mice were transplanted with 1×10 5 total bone marrow cells obtained either from mice that had previously received 1×10 5 
CD97
INT bone marrow cells or from recipients of 1 ×10 5 total bone marrow cells. At 150 days following transplantation, four of the five mice that were secondary recipients of CD97 INT bone marrow cells and four of the five secondary recipients of 1×10 5 total bone marrow cells were radioprotected (p<0.01 compared to irradiated controls; Figure 3B ). FACS analysis revealed that all hematopoietic lineages were reconstituted in all of the radioprotected recipient mice (data not shown).
Together, these results indicate that the CD97 INT bone marrow cell fraction contains HSC with long-term repopulating ability in vitro and in vivo.
CD97 is differentially expressed on BALB/c, C57BL/6 and DBA/1 hematopoietic stem cell
To evaluate the expression of CD97 on cells that are phenotypically characterized as HSC, total unseparated bone marrow cells were stained for CD97, c-Kit, Thy- INT transplanted bone marrow cells were sacrificed on day 126 after bone marrow transplantation and bone marrow cells were harvested. Subsequently, 1x10 5 total bone marrow cells were administered to lethally irradiated (9.5 Gy) second recipients (n=5 per group). Figure  4) . Next, Hoechst 33342 dye efflux was used as a marker to identify the hematopoietically active bone marrow cell subset known as the side population. 24 We used the side population as an additional selection criterion for HSC, in combination with c-Kit 
The CD97
INT c-Kit HI phenotype confers long-term repopulating ability and is highly enriched for HSC
The isolation of murine HSC is a multistep process, consisting of both positive and negative selection. 4 To investigate whether long-term repopulating HSC in BALB/c mice can be isolated based on CD97 and c-Kit expression levels, we investigated the HSC and HPC content of CD97 INT expression ( Figure 5A , 5B). To investigate the repopulating ability of bone marrow cell subsets that are enriched for HSC activity, lethally irradiated recipient mice were transplanted with either 1×10 5 c-Kit HI or 1×10 5 c-Kit
INT bone marrow cells (n=5 per group). Sixty percent of the mice that were transplanted with c-Kit HI bone marrow cells survived long-term (i.e. >150 days), whereas the radioprotection rate of c-Kit HI CD97
INT bone marrow cells was 100% ( Figure 5C ).
In conclusion, these in vitro and in vivo data indicate that addition of CD97
INT as a selection marker for primitive HSC leads to a significant further enrichment of primitive stem cells.
Discussion
CD97 is a cell-surface molecule that is expressed on cells of the immune system. 15, 16 It is a member of the EGF-TM7 family of adhesion class heptahelical receptors. In the present study, we investigated the expression of CD97 on hematopoietic stem-and progenitor cells obtained from different mouse strains. We show that committed progenitor cell activity is largely present in the CD97 NEG fraction, while the CD97 INT popula- tion of all mouse strains contains HSC activity, although there are differences in levels of CD97 expression between the individual strains. Murine HSC are phenotypically defined by a complex expression of different surface molecules. 4, 5, 6 As a consequence, the isolation of primitive HSC involves a procedure that requires both magnetic and fluorescent cell sorting steps. Here, we show that primitive HSC can be easily isolated on the basis of CD97 and c-Kit expression. Furthermore, we show that using CD97 as a marker, in combination with the conventional HSC isolation methods, leads to enrichment of a bone marrow cell population that contains a higher frequency of HSC with radioprotective and long-term repopulating abilities. We show that CD97 can be successfully applied to enrich for primitive HSC. Addition of CD97
INT as a selection marker to c-Kit HI leads to a more than 2-fold increase in CAFC-day 28 activity. Furthermore, addition of selection of CD97
INT bone marrow cells in combination with c-Kit Preliminary data on CD97 expression on human bone marrow cells showed that, as for murine bone marrow cells, human bone marrow cells can be divided
